Unknown

Dataset Information

0

Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in Singapore.


ABSTRACT: Next-generation sequencing (NGS)-based diagnostics have demonstrated clinical utility in predicting improved survival benefits with targeted treatment in certain cancer types, and positive cost-benefit in several healthcare systems. However, clinical adoption in Singapore remains low despite commercial availability of these diagnostics. This expert opinion review examines the key challenges to the clinical adoption of NGS-based diagnostics in Singapore, provides recommendations on impactful initiatives to improve adoption, and also offers practical guidance on specific cancer types in which NGS-based diagnostics are appropriate for use in Singapore. Limited patient affordability is one major challenge to clinical adoption of NGS-based diagnostics, which could be improved by enabling patient access to more funds for specific cancer types with clear benefits. Expert opinion based on current evidence and clinical experience supports the upfront use of hotspot panels in advanced non-small cell lung cancer (NSCLC), metastatic colorectal cancer, advanced and recurrent ovarian cancer, and acute myeloid leukemia. Comprehensive genomic profiling could be considered for upfront use in select patients with NSCLC and ovarian cancer, or in refractory patients with the four cancer types. Wider adoption of NGS-based diagnostics will improve the delivery of cancer care in Singapore and Asia-Pacific, and thus lead to better patient outcomes.

SUBMITTER: Tan DS 

PROVIDER: S-EPMC7496576 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in Singapore.

Tan David Shao-Peng DS   Tan Daniel Shao-Weng DS   Tan Iain Bee Huat IBH   Yan Benedict B   Choo Su Pin SP   Chng Wee Joo WJ   Hwang William Ying Khee WYK  

Asia-Pacific journal of clinical oncology 20200416 4


Next-generation sequencing (NGS)-based diagnostics have demonstrated clinical utility in predicting improved survival benefits with targeted treatment in certain cancer types, and positive cost-benefit in several healthcare systems. However, clinical adoption in Singapore remains low despite commercial availability of these diagnostics. This expert opinion review examines the key challenges to the clinical adoption of NGS-based diagnostics in Singapore, provides recommendations on impactful init  ...[more]

Similar Datasets

| S-EPMC4836299 | biostudies-literature
| S-EPMC6581937 | biostudies-literature
2019-12-19 | GSE142293 | GEO
| S-EPMC5518446 | biostudies-literature
| S-EPMC7771457 | biostudies-literature
| S-EPMC11016705 | biostudies-literature
| S-EPMC5896995 | biostudies-literature
| S-EPMC5386488 | biostudies-literature
| S-EPMC1828942 | biostudies-literature